Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network
NCT07165535 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2025-09-10
Summary
The primary objective of the study is to assess the impact of the organizational model of the hematology center on the quality of life of patients with CML estimated through standardized tools (EORTC QLQ-30, CML24) and through the patient's opinion regarding aspects of the quality of care.
Conditions
- Chronic Myeloid Leukemia (CML)
Sponsors & Collaborators
-
University of Milano Bicocca
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-17
- Primary Completion
- 2026-05-17
- Completion
- 2026-05-17
Countries
- Italy
Study Locations
More Related Trials
-
Immunophenotyping of Blood Cells in the Diagnosis Work-up of Myelodysplastic Syndromes
NCT03621241 ·Status: RECRUITING
-
Relevance of Peripheral Cells in the Pathophysiology of Chronic Myelomonocytic Leukemia (CMML)
NCT03280888 ·Status: UNKNOWN
-
Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients
NCT03090477 ·Status: COMPLETED ·Phase: NA
-
Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy
NCT03096496 ·Status: UNKNOWN
-
Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia
NCT03789981 ·Status: ACTIVE_NOT_RECRUITING
-
Quality of Life Model for Older Patients With AML
NCT04380441 ·Status: ACTIVE_NOT_RECRUITING
-
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024 ·Status: RECRUITING
-
Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia
NCT06535113 ·Status: RECRUITING
-
Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia
NCT02714790 ·Status: COMPLETED
-
Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis
NCT06042660 ·Status: COMPLETED
-
Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
NCT00002771 ·Status: UNKNOWN ·Phase: PHASE3
-
Allogeneic SCT for CML, TKI Failure After TKI Failure
NCT02172365 ·Status: UNKNOWN
-
Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
NCT00459524 ·Status: COMPLETED
-
Chronic Myelod Leukemia Registry at Asan Medical Center
NCT01761695 ·Status: TERMINATED
-
Assessing Refractoriness and Infectious Survival Events in AML
NCT06709235 ·Status: COMPLETED
-
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
NCT04460950 ·Status: RECRUITING
-
A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy
NCT03310918 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
NCT02975869 ·Status: COMPLETED ·Phase: NA
-
A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia
NCT00400673 ·Status: COMPLETED ·Phase: PHASE2
-
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors
NCT03481868 ·Status: RECRUITING ·Phase: NA
-
Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways
NCT05124288 ·Status: RECRUITING
-
Quality of Life-Guided Transfusion in Refractory MDS or AML
NCT07328191 ·Status: RECRUITING ·Phase: NA
-
Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75
NCT03902665 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Adult ALL With an MRD-directed Programme.
NCT00358072 ·Status: COMPLETED ·Phase: PHASE2
-
Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival
NCT01188330 ·Status: UNKNOWN ·Phase: NA